AlphaFold predicted structure
GYS1 · P13807

Mean pLDDT
84.4/ 100
Confident
737 residues
Confidence breakdown
- Very high(≥ 90)72%
- Confident(70–90)9%
- Low(50–70)4%
- Very low(< 50)15%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glycogen synthase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Hyperammonaemia
Ketotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalglycogen storage disease due to muscle and heart glycogen synthase deficiency
disorder of glycogen metabolism
neurodegenerative disease
Glycogen storage disease due to glycogenin deficiency
hereditary disease
breast carcinoma
breast cancer
nonpapillary renal cell carcinoma
hypertrophic cardiomyopathy
Rare familial disorder with hypertrophic cardiomyopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glycogen [starch] synthase, muscle
Glycogen synthase participates in the glycogen biosynthetic process along with glycogenin and glycogen branching enzyme. Extends the primer composed of a few glucose units formed by glycogenin by adding new glucose units to it. In this context, glycogen synthase transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan
GYS1 · P13807

Mean pLDDT
84.4/ 100
Confident
737 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0